Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com//news-release/2024/02/05/2823613/0/en/Discoverer-of-the-Klotho-Gene-and-Pioneer-in-Longevity-and-Disease-Prevention-Dr-Makoto-Kuro-o-Joins-Scientific-Advisory-Board-of-ADvantage-Therapeutics.html
https://www.globenewswire.com//news-release/2023/11/27/2786190/0/en/ADvantage-Therapeutics-Has-Commenced-Enrollment-for-Its-Phase-2b-Clinical-Trial-of-AD04-for-Treatment-of-Alzheimer-s-Disease.html
https://www.globenewswire.com//news-release/2023/10/02/2752951/0/en/Klogenix-pioneering-research-on-age-related-diseases-and-longevity-gene-Klotho-finds-new-home-at-ADvantage-Therapeutics-Inc.html
https://www.globenewswire.com//news-release/2023/10/02/2752924/0/en/ADvantage-Therapeutics-Welcomes-Esteemed-Expert-in-Alzheimer-s-Disease-and-Klotho-Protein-Carmela-Abraham-Ph-D-as-Chief-Science-Officer.html
https://www.globenewswire.com/news-release/2023/06/20/2691175/0/en/ADvantage-Therapeutics-Secures-Approvals-for-Clinical-Trial-of-AD04-in-Alzheimer-s-Disease-Treatment-in-Poland-Bulgaria-and-Slovakia.html
https://www.globenewswire.com/news-release/2023/04/05/2641695/0/en/MHRA-Grants-ADvantage-Therapeutics-Innovative-Licensing-and-Access-Pathway-ILAP-Designation-for-Novel-Lead-Product-AD04-for-Phase-2b-Trial-in-Alzheimer-s-Disease.html
https://www.globenewswire.com/news-release/2023/03/24/2633994/0/en/Renowned-Public-Health-Advisor-Jim-O-Neill-Joins-Board-of-Directors-of-ADvantage-Therapeutics.html